📄 "Epstein-Barr virus-associated tumors: commonalities in pathogenesis and the tumor immune microenvironment" . EBV ( May 11, 2026 at 03:36PM)
https://pubmed.ncbi.nlm.nih.gov/42112354/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260511143606&v=2.20.0

📄 "Loss of systemic anti-viral immunity and LMP1-driven suppressive myeloid tumour niches converge to shape the immunobiology of Epstein-Barr virus-positive diffuse large B-cell lymphoma" . EBV ( June 11, 2026 at 11:15AM)
https://pubmed.ncbi.nlm.nih.gov/42271039/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260611101537&v=2.20.0

📄 "JAK2 Degradation by Strebloside Dismantles PD-L1-Mediated Immune Evasion in EBV-Associated Gastric Cancer" . EBV ( June 11, 2026 at 11:15AM)
https://pubmed.ncbi.nlm.nih.gov/42269762/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260611101537&v=2.20.0

📄 "Diagnostic Significance of Circulating EBV-miR-BHRF1-3 and EBV-miR-BART2-5p in Lymphoma A Case-Control Study" . EBV ( June 8, 2026 at 05:17PM)
https://pubmed.ncbi.nlm.nih.gov/42257093/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260608161735&v=2.20.0

📄 "Progress towards an Epstein-Barr virus vaccine" . EBV ( June 8, 2026 at 05:17PM)
https://pubmed.ncbi.nlm.nih.gov/42253055/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260608161735&v=2.20.0

📄 "Circular RNAs in tumor biology and immunology: molecular mechanisms and therapeutic implications" . Mol Cancer ( June 13, 2026 at 08:52AM)
https://pubmed.ncbi.nlm.nih.gov/42286649/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=00QaWMiXFBEMKNV_qHo-KmRhFk2n8N-2OaTrSFg24S6&fc=None&ff=20260613075243&v=2.20.0

📄 "Epstein-Barr Virus in Brain Cancer-Friend or Foe?" . EBV ( June 12, 2026 at 11:47AM)
https://pubmed.ncbi.nlm.nih.gov/42278342/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260612104729&v=2.20.0

📄 "Epstein-Barr Virus MicroRNAs as Key Regulators of Lymphoma Pathogenesis: Immune Evasion Mechanisms and Therapeutic Opportunities" . Vírus e Câncer ( June 29, 2026 at 03:47AM)
https://pubmed.ncbi.nlm.nih.gov/42365855/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260629024738&v=2.20.0

📄 "Epstein-Barr virus-driven immunosuppression in nasopharyngeal carcinoma: a comprehensive review of viral mechanisms, spatial tumor ecosystems, and precision therapeutics" . Vírus e Câncer ( July 2, 2026 at 10:13AM)
https://pubmed.ncbi.nlm.nih.gov/42389513/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260702091326&v=2.20.0

📄 "Epstein-Barr virus downregulates breast cancer gene 1 to facilitate GPX4-dependent ferroptosis resistance and tumor growth of B-cell lymphoma" . Vírus e Câncer ( July 5, 2026 at 03:27AM)
https://pubmed.ncbi.nlm.nih.gov/42401412/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260705022732&v=2.20.0

📄 "EBV and immunodeficiency: the odd couple drawn to the brain" . EBV ( July 2, 2026 at 03:33PM)
https://pubmed.ncbi.nlm.nih.gov/42390876/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260702143344&v=2.20.0

📄 "Epstein-Barr virus-driven immunosuppression in nasopharyngeal carcinoma: a comprehensive review of viral mechanisms, spatial tumor ecosystems, and precision therapeutics" . EBV ( July 2, 2026 at 08:41AM)
https://pubmed.ncbi.nlm.nih.gov/42389513/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260702074128&v=2.20.0

📄 "Extracellular vesicles from wild-type Epstein-Barr virus-transformed B-cells export host DNA and EBV EBER1" . EBV ( July 2, 2026 at 08:41AM)
https://pubmed.ncbi.nlm.nih.gov/42388793/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260702074128&v=2.20.0

📄 "KSHV-infected endothelial cells expand and up-regulate angiogenic pathways and CXCR4 in patient-derived Kaposi sarcoma models" . KSHV/HHV-8 ( July 1, 2026 at 11:03PM)
https://pubmed.ncbi.nlm.nih.gov/42384773/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0MbwdG8oCHuS3zShObm9OxM2igUrv8WmS1-6Xt5ghCU&fc=None&ff=20260701220310&v=2.20.0

📄 "CD44 expression associates with EBV LMP1, reduced CD8+ T cell infiltration, and lower PD-L1 combined positive score in nasopharyngeal carcinoma" . EBV ( June 30, 2026 at 12:15PM)
https://pubmed.ncbi.nlm.nih.gov/42374504/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260630111542&v=2.20.0

📄 "Epstein-Barr Virus-host epigenetic interplay: mechanisms of regulation and therapeutic potential" . EBV ( July 7, 2026 at 04:35AM)
https://pubmed.ncbi.nlm.nih.gov/42410445/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260707033546&v=2.20.0

📄 "Prevalence of Epstein-Barr virus infection in North African cancer patients: a systematic review and meta-analysis protocol" . Vírus e Câncer ( July 9, 2026 at 09:08AM)
https://pubmed.ncbi.nlm.nih.gov/42421079/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260709080838&v=2.20.0

📄 "The Complex Interplay of Malaria and EBV in Burkitt Lymphoma" . EBV ( July 15, 2026 at 02:09PM)
https://pubmed.ncbi.nlm.nih.gov/42449688/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260715130921&v=2.20.0

📄 "BFLF1 gene polymorphisms are associated with increased mortality in patients with EBV-associated diseases" . EBV ( July 15, 2026 at 02:09PM)
https://pubmed.ncbi.nlm.nih.gov/42449423/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260715130921&v=2.20.0

📄 "Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma: a pooled analysis of four prospective cohorts" . Vírus e Câncer ( July 16, 2026 at 05:03AM)
https://pubmed.ncbi.nlm.nih.gov/42457673/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260716040331&v=2.20.0

📄 "Repression of productive viral replication by KSHV LANA correlates with reduced adaptive immune activation: potential implications for KSHV immune evasion" . KSHV/HHV-8 ( July 23, 2026 at 03:56PM)
https://pubmed.ncbi.nlm.nih.gov/42489446/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0MbwdG8oCHuS3zShObm9OxM2igUrv8WmS1-6Xt5ghCU&fc=None&ff=20260723145629&v=2.20.0